Literature DB >> 15148521

Occurrence of substance P(1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level.

C Sakurada1, C Watanabe, T Sakurada.   

Abstract

Substance P (SP), which is known as a pain transmitter or modulator in the spinal cord, was degraded by the synaptic membranes of the mouse spinal cord. The major metabolites of SP were phenylalanine, SP(1-6), SP(1-7), SP(1-9), SP(8-9) and SP(10-11). Degradation of SP was inhibited by a metal chelator, o-phenanthroline, and also by specific inhibitors of endopeptidase-24.11, thiorphan and phosphoramidon. In contrast, captopril (a specific inhibitor of angiotensin-converting enzyme), bestatin (a specific inhibitor of aminopeptidase) and Z-321 (a specific inhibitor of prolylendopeptidase) showed little effect on the degradation of SP. The accumulation of the major cleavage products was strongly inhibited by phosphoramidon and thirophan, as well as the initial cleavage of SP. Thus, endopeptidase-24.11 plays a major role in SP degradation in the mouse spinal cord. Additional in vivo experiments were performed to investigate the antinociceptive effect of SP(1-7), a major product of SP that was detected after incubation with spinal synaptic membranes. In the mouse tail-flick test, the intrathecal administration of SP(1-7) (1.0-4.0 pmol) increased tail-flick latency in a dose-dependent manner. These results suggest that degradation of SP by spinal endopeptidase-24.11 may lead to the formation of SP(1-7), which has an ability to produce antinociceptive effects at the mouse spinal cord level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148521     DOI: 10.1358/mf.2004.26.3.809722

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  4 in total

1.  Exploration and pharmacokinetic profiling of phenylalanine based carbamates as novel substance p 1-7 analogues.

Authors:  Rebecca Fransson; Gunnar Nordvall; Johan Bylund; Anna Carlsson-Jonsson; Jadel M Kratz; Richard Svensson; Per Artursson; Mathias Hallberg; Anja Sandström
Journal:  ACS Med Chem Lett       Date:  2014-10-29       Impact factor: 4.345

2.  Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling.

Authors:  Dirk Roosterman; Graeme S Cottrell; Benjamin E Padilla; Laurent Muller; Christopher B Eckman; Nigel W Bunnett; Martin Steinhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

3.  The Analgesic Activity of Bestatin as a Potent APN Inhibitor.

Authors:  Mei-Rong Jia; Tao Wei; Wen-Fang Xu
Journal:  Front Neurosci       Date:  2010-06-28       Impact factor: 4.677

4.  The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activation.

Authors:  Lin Hsin; Nithya A Fernandopulle; Jie Ding; Chris Lumb; Nicholas Veldhuis; John A Karas; Susan E Northfield; Graham A Mackay
Journal:  Pharmacol Res Perspect       Date:  2022-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.